Cutibacterium acnes persists despite topical clindamycin and benzoyl peroxide

• Published in: Journal of shoulder and elbow surgery Vol. 28; no. 12; pp. 2279 - 2283
• Main Authors: Heckmann, Nathanael, Heidari, K. Soraya, Jalali, Omid, Weber, Alexander E., She, Rosemary, Omid, Reza, Vangsness, C. Thomas, “Rick” Hatch, George F.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.12.2019
• Subjects: Administration, Cutaneous; Adult; Anti-Bacterial Agents - administration & dosage; Anti-Infective Agents, Local - administration & dosage; Back; Benzoyl Peroxide - administration & dosage; C acnes; Clindamycin - administration & dosage; Drug Therapy, Combination; Female; Healthy Volunteers; Humans; Male; P acnes; Propionibacterium acnes - isolation & purification; Random Allocation; Shoulder; Skin - microbiology; skin antisepsis; topical antibiotics; Treatment Study; skin antisepsis; Shoulder; Level II; Prospective Cohort Design; P acnes; topical antibiotics; C acnes
• ISSN: 1058-2746; 1532-6500; 1532-6500
• DOI: 10.1016/j.jse.2019.06.016

Cutibacterium (formerly Propionibacterium) acnes persists in the dermis despite standard skin antiseptic agents, prompting some surgeons to use topical antimicrobials such as benzoyl peroxide and clindamycin prior to shoulder arthroplasty surgery. However, the efficacy of these topical agents has not been established. The upper backs of 12 volunteers were randomized into 4 treatment quadrants: topical benzoyl peroxide, topical clindamycin, combination topical benzoyl peroxide and clindamycin, and a negative control. The corresponding topical agents were applied to each site twice daily for 3 days. A 3-mm dermal punch biopsy specimen was obtained from each site and cultured for 14 days to assess for C acnes growth. Positive cultures were assessed for the hemolytic phenotype. The McNemar test was used to compare the proportion of positive cultures in each group. C acnes grew in 4 of 12 control sites (33.3%), 1 of 12 benzoyl peroxide sites (8.3%), 2 of 12 clindamycin sites (16.7%), and 2 of 12 combination benzoyl peroxide–clindamycin sites (16.7%). The C acnes hemolytic phenotype was present in 2 of 12 control specimens (16.7%) compared with 0 (0.0%) in the benzoyl peroxide group, 2 of 12 (16.7%) in the clindamycin group, and 2 of 12 (16.7%) in the combination benzoyl peroxide–clindamycin group. There were no statistically significant differences between treatment arms. The topical application of benzoyl peroxide and clindamycin did not eradicate C acnes in all subjects. The clinical implications of these findings are yet to be determined.